Aspire Biopharma Holdings (ASBP) Other financing activities (2022 - 2025)
Aspire Biopharma Holdings' (ASBP) quarterly Other financing activities came in at -$1.0 in Q3 2025, down 100.0% on a QoQ basis from $265828.0 in Q1 2025.
Aspire Biopharma Holdings (ASBP) Other financing activities (2022 - 2025) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 2 years of Other financing activities data on file, last reported at -$1.0 in Q3 2025.
- On a quarterly basis, Other financing activities changed N/A year-over-year to -$1.0 in Q3 2025; TTM through Dec 2025 was $265827.0, a N/A change from a year earlier, with the FY2025 full-year figure at $265827.0, down 84.47% from the prior year.
- Other financing activities for Q3 2025 stood at -$1.0, down from $265828.0 in the prior quarter.
- Over the last five years, Other financing activities for ASBP reached as high as $14.6 million in Q1 2022 and fell as low as -$1.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Aspire Biopharma Holdings | 1.09 Mn | -733,865.14 | 5,750.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.00 |
| Sep 30, 2025 | -1.00 |
| Mar 31, 2025 | 265,828.00 |
| Mar 31, 2025 | 265,828.00 |
| Mar 31, 2022 | 14.65 Mn |
| Mar 31, 2022 | 14.65 Mn |